bicalutamide has been researched along with Insulin Sensitivity in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, P; Corman, JM; Dalkin, BL; Dean, JP; Ellis, WJ; Haugk, K; Lin, DW; Montgomery, B; Mostaghel, E; Nelson, PS; Plymate, SR; Sprenger, CC; Wan, J | 1 |
Aslan, C; Bahceci, M; Canoruc, N; Kidir, V; Tuzcu, A; Tuzun, Y | 1 |
Hirsch, IB; Paniagua, MA | 1 |
Fallon, MA; Lee, H; Nathan, DM; Smith, MR | 1 |
2 trial(s) available for bicalutamide and Insulin Sensitivity
Article | Year |
---|---|
Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivation.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Cohort Studies; Goserelin; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 1; Male; Neoadjuvant Therapy; Nitriles; Obesity; Prostatectomy; Prostatic Neoplasms; Receptor, IGF Type 1; Risk; Secondary Prevention; Somatomedins; Tosyl Compounds; United States | 2013 |
Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance.
Topics: Adult; Androgen Antagonists; Anilides; Anthropometry; Blood Glucose; C-Reactive Protein; Female; Hirsutism; Hormones; Humans; Insulin Resistance; Lipids; Nitriles; Polycystic Ovary Syndrome; Tosyl Compounds | 2004 |
2 other study(ies) available for bicalutamide and Insulin Sensitivity
Article | Year |
---|---|
Insulin resistance as an adverse effect of leuprolide and bicalutamide treatment.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Humans; Insulin Resistance; Leuprolide; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2005 |
Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer.
Topics: Adipokines; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Body Composition; Drug Therapy, Combination; Humans; Insulin Resistance; Leuprolide; Male; Nitriles; Obesity; Prospective Studies; Prostatic Neoplasms; Tosyl Compounds | 2008 |